AI-Driven Consent Simplification Study (NCT07303517)
ACCESS: AI-Driven Consent Simplification Study
๐ฉบ Plain-English Summary (8th-Grade Level)
The overarching goal of this pilot is to explore how generative artificial intelligence (genAI) can be used to improve the accessibility and understandability of informed consent materials in clinical research. The study will test the extent to which informed consent text can be improved by large language models (LLM; specifically, ChatGPT and NotebookLM) along with other AI tools (specifically, ElevenLabs) through qualitative and quantitative analyses. Simplifying such forms using genAI may facilitate better comprehension, ensuring truly informed consent. Improving informed consent form (ICF) comprehension can lead to more informed and willing participation in clinical studies. This improved understanding may result in higher enrollment rates, better subject retention, and more accurate data collection as individuals will have a clearer understanding of study procedures and risks.
Who can join: Review the eligibility criteria below.
Location: UCLA โ Los Angeles, California
Age range: 18 Years
๐งช Interventions in This Study
- Original ICF (BEHAVIORAL)
- AI Simplified ICF (BEHAVIORAL)
- Podcast - Original ICF (BEHAVIORAL)
- Podcast - Simplified ICF (BEHAVIORAL)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- UCLA โ Los Angeles, California
๐ Contact the Study Coordinator
Phone: (310) 490-4888
Email: eknox@mednet.ucla.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Informed Consent
- Digital-Supported Versus Standard Consent for Advanced Therapeutic Endoscopy โ Toronto, Ontario
- Chatbot Implementation In The Clinical Informed Consent Process โ Houston, Texas
Explore by condition: All Informed Consent clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.